Shu Xia
Impact in
- Molecular Medicine top 5%
- Antibiotic Resistance in Bacteria
- Endocrinology top 10%
- Escherichia coli research studies
Papers in
-
- Lung Cancer Treatments and Mutations 10
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis 7
- Respiratory and Cough-Related Research 6
- Occupational and environmental lung diseases 4
- Oncology 16
- Lung Cancer Research Studies 6
- Co-authors
- Meijun Du (6 shared papers)Liang Wang (6 shared papers)Chao Zhuo (2 shared papers)Rachel L. Dittmar (5 shared papers)Shiying Yu (8 shared papers)Chiang‐Ching Huang (4 shared papers)Liang Zhuang (5 shared papers)Yingchun Xu (1 shared paper)
- Journals
- Frontiers in Molecular Biosciences (3 papers)Supportive Care in Cancer (2 papers)Cancer Research (2 papers)Scientific Reports (1 paper)Journal of Thoracic Oncology (1 paper)
- Partner nations
- ChinaUnited StatesAustralia
In The Last Decade
Shu Xia
53 papers receiving 667 citations
Peers
Comparison fields: 5 of 85
- Molecular Medicine 107
- Endocrinology 64
- Cancer Research 159
- Pulmonary and Respiratory Medicine 228
- Oncology 148
Countries citing papers authored by Shu Xia
This map shows the geographic impact of Shu Xia's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shu Xia with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shu Xia more than expected).
Fields of papers citing papers by Shu Xia
This network shows the impact of papers produced by Shu Xia. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shu Xia. The network helps show where Shu Xia may publish in the future.
Co-authors
The 25 scholars most cited alongside Shu Xia, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 56 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2014 | 65 | |
| 2 | 2017 | 49 | |
| 3 | 2017 | 45 | |
| 4 | 2014 | 44 | |
| 5 | 2015 | 39 | |
| 6 | 2015 | 38 | |
| 7 | 2021 | 30 | |
| 8 | 2013 | 26 | |
| 9 | 2020 | 23 | |
| 10 | 2012 | 19 | |
| 11 | 2017 | 18 | |
| 12 | 2022 | 17 | |
| 13 | 2013 | 17 | |
| 14 | 2019 | 16 | |
| 15 | 2020 | 15 | |
| 16 | 2024 | 14 | |
| 17 | 2021 | 13 | |
| 18 | 2015 | 12 | |
| 19 | 2018 | 12 | |
| 20 | 2021 | 12 |
About Shu Xia
Shu Xia is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Molecular Biology, Physiology and Cancer Research, having authored 56 papers that have together received 673 indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (10 papers), Allergic Rhinitis and Sensitization (8 papers), Asthma and respiratory diseases (8 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (7 papers), Cancer Genomics and Diagnostics (6 papers), Lung Cancer Research Studies (6 papers), Respiratory and Cough-Related Research (6 papers) and Occupational and environmental lung diseases (4 papers). The work is most often cited by research in Molecular Medicine (107 citations), Endocrinology (64 citations), Cancer Research (159 citations), Pulmonary and Respiratory Medicine (228 citations) and Oncology (148 citations). Shu Xia has collaborated with scholars based in China, United States and Australia. Frequent co-authors include Meijun Du, Liang Wang, Chao Zhuo, Rachel L. Dittmar, Shiying Yu, Chiang‐Ching Huang, Liang Zhuang, Yingchun Xu, Xin Fan and Meng Xiao. Their work appears in journals such as Frontiers in Molecular Biosciences, Supportive Care in Cancer, Cancer Research, Scientific Reports and Journal of Thoracic Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.